Extracorporeal Membrane Oxygenation for Acute Decompensated Heart Failure

Area of Science:

• Cardiology
• Critical Care Medicine
• Cardiovascular Surgery

Background:

• Long-term outcomes of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) for acute decompensated heart failure (ADHF) remain underreported.
• ADHF, often complicated by cardiogenic shock in chronic cardiomyopathy, requires advanced support strategies.

Purpose of the Study:

• To describe the long-term outcomes of patients treated with VA-ECMO for ADHF.
• To identify factors associated with mortality in this patient population.

Main Methods:

• Retrospective analysis of prospectively collected data from 105 patients with ADHF treated with VA-ECMO.
• Data included pre-implantation Sequential Organ Failure Assessment (SOFA) scores, cardiac disease duration, and blood lactate levels.

Main Results:

• The 1-year survival rate was 42%.
• Independent predictors of 1-year mortality included higher pre-ECMO SOFA scores (>11), idiopathic cardiomyopathy, longer cardiac disease duration (>2 years), and elevated pre-ECMO blood lactate (>4 mmol/L).
• Patients with pre-ECMO SOFA scores < 11 had significantly better survival rates.

Conclusions:

• VA-ECMO is a viable option for ADHF, with a 42% 1-year survival in this cohort.
• Optimal timing of VA-ECMO implantation, guided by pre-procedural assessment (e.g., SOFA score), is critical for improving patient outcomes.